GEN News Highlights: Jan 11, 2012

Cofactor Genomics Offers Intrepid Bioinformatics' Genomic Viewer for Bovine Exome Capture Product

(Page 1 of 1)

    Cofactor Genomics will offer customers of its Bovine whole-exome capture product a genomic viewer from Intrepid Bioinformatics for visualizing the resulting sequencing data of the Bos taurus.

    Intrepid Bioinformatics’ SNP data service allows researchers to load and examine data down to the sequence read while viewing polymorphisms, exons and introns, allele frequencies, and more. The service will be integrated into Cofactor’s capture product, forming what the companies say is an end-to-end solution for researchers to quantify, discover, and visualize genomic variation from the cow genome.

    Last month, Cofactor announced the launch of its Bos taurus exome capture product, which provides sequence-verified SNPs, insertions, and deletions, without any prior knowledge of genomic variation. The company says its product is designed to let researchers selectively enrich, sequence, analyze, and detect variants in coding and regulatory regions of the cow genome.

     


Related content

GEN News Highlights

Insight & Intelligence™

GEN Articles

BLOG biotech

Application Notes

Webinars

GEN Podcasts

New Products

Best of the Web

Subscription center

GEN MAGAZINE

Genetic Engineering & Biotechnology News (GEN) has retained its position as the most widely read biotechnology publication around the globe since its launch in 1981. Published 21 times a year and with additional exclusive editorial content online, GEN's unique news and technology focus includes the entire bioproduct life cycle from early-stage R&D, to applied research including omics, biomarkers, as well as diagnostics, to bioprocessing and commercialization.

Subscribe

e-NEWSLETTERS

Add GEN to your Inbox! Subscribe today to our complimentary e-newsletters and stay abreast of the latest biotech news and trends. Click the magnifying glass icon next to a newsletter title to view a sample.

 

All fields are required

Email
  Confirm Email
  First Name
  Last Name
  Organization
  E-Alert Format
 
 
  Sign Up

ADVERTISEMENT

ADVERTISEMENT

ADVERTISEMENT

GENpoll

FDA Performance

How much progress do you think FDA has made in reviewing drugs and bringing them to market faster?

Suggest a Poll